• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.79% Nasdaq Up0.53%

    INSYS Therapeutics, Inc. (INSY)

    -NasdaqGM
    35.51 Down 0.41(1.14%) Jul 1, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 222,125   99,289   15,476  
    Cost of Revenue22,578  12,665  7,627  
    Gross Profit 199,547   86,624   7,849  
    Operating Expenses
    Research Development33,136  8,499  6,305  
    Selling General and Administrative102,388  45,566  19,581  
    Non Recurring -   -  5,403  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 64,023   32,559   (23,440)
    Income from Continuing Operations
    Total Other Income/Expenses Net153  (32)1,746  
    Earnings Before Interest And Taxes64,176  32,527  (21,694)
    Interest Expense -  950  2,684  
    Income Before Tax64,176  31,577  (24,378)
    Income Tax Expense26,199  (8,800) -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops37,977  40,377  (24,378)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 37,977   40,377   (24,378)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 37,977   40,377   (24,378)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.